
Florida Cancer Specialists & Research Institute Innovations in Precision Oncology Informatics Showcased at World Conference

Trevor Heritage, PhD presents insights at PMWC® 2024.
Fort Myers, Fla., January 23, 2024 –
“FCS PRECISE™, our propriety precision oncology system, is critical in precision oncology decision-making, leading to optimal experiences and outcomes for our patients,” said Dr. Heritage. “I am delighted to join with other industry pioneers to help accelerate advances that will enable effective adoption of precision medicine in community oncology.”
The FCS PRECISE™ system aggregates and standardizes discrete, genomic variant information derived from next-generation sequencing (NGS) testing conducted at FCS’ in-house molecular laboratory, as well as external references labs. Dr. Heritage heads FCS’ growing Precision Oncology Informatics Team focused on optimizing the delivery and integration of molecular data and decision-support capabilities to physicians and patients.
“Thanks to our forward-thinking investments, we are now able to leverage our in-house data to accurately examine each patient’s unique molecular biomarkers and identify very specific and targeted treatments, including matches for clinical trial opportunities, and we are able to do it much faster and more completely than ever before,” added
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.